Table of contents for Lupus, 29, 6, May 01, 2020.
Lupus is a chronic inflammatory autoimmune disease with a wide range of clinical presentations resulting from its effect on multiple organ systems. Our objective was to update the EULAR recommendations for the management of systemic lupus erythematosus (SLE), based on emerging new evidence. Accepted 2012 Feb 14. P T. 2012 Apr; 37 (4): 240-246, 249. Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus, Nature Communications (2019). This article has been cited by other articles in PMC. New research on the autoimmune disease systemic lupus erythematosus (SLE) provides hints to the origins of the puzzling disorder. The results were published Monday in Nature Immunology. Lupus includes the most promising new clinical and laboratory-based studies from leading specialists in all lupus-related disciplines. The only fully peer reviewed international journal devoted exclusively to lupus (and related disease) research.
Systemic lupus erythematosus (SLE) is the prototype of autoimmune disease, of unknown etiology, although its mechanisms involve genetic, epigenetic and environmental risk factors. A comparison of the performance of the 2019 European League Against Rheumatism/American College of Rheumatology criteria and the 2012 Systemic Lupus International Collaborating Clinics criteria with the 1997 American College of Rheumatology classification criteria for systemic lupus erythematous in new-onset Chinese patients Treatment in SLE aims at remission or low disease activity and prevention of … Lupus is a chronic autoimmune disease in which the immune system produces autoantibodies that attack healthy cells and tissues, including those of … We performed a systematic literature review (01/2007–12/2017), followed by modified Delphi method, to form questions, elicit expert opinions and reach consensus. About this journal. Lupus Science & Medicine is delighted to again be the official journal of the Annual Meeting of the Lupus Academy, which will be held in Florence in September 2020.Chaired by LSM Co-Editor Ronald van Vollenhoven and Andrea Doria, the event promises to deliver insights into cutting edge developments in lupus research and clinical practice. See " Belimumab (Benlysta) " on page 212.
More information: Simon H. Jiang et al.